Oncology Letters · 2020 · 80 citations · 31 references
Life SciencesBiochemistryOncologyLipid BiochemistryMetabolismMetastasisCancer MetabolismFatty Acid BiosynthesisFatty Acid MetabolismFatty Acid SynthesisLipid MetabolismMetastatic Breast CancerBreast Cancer ProgressionCancer Metastasis BiomarkersCancer Metastasis MechanismsDe Novo Fatty Acid SynthesisFatty Acid Synthase MechanismFatty AcidsRegulation Of Fatty Acid MetabolismTumor Metastasis Biology
Fatty acid metabolism is closely associated with the occurrence and development of tumors. The aim of the present study was to investigate whether the key enzyme involved in fatty acid synthesis, fatty acid synthase (FASN), mediates fatty acid changes that affect the activity and migration of breast cancer cells, and whether specific fatty acids play a role in tumor metastasis. The difference in serum fatty acid profiles between patients with invasive ductal carcinoma (IDC) and healthy controls was evaluated by gas chromatography-mass spectrometry (GC-MS) fatty acid profile analysis, and it was revealed that five types of fatty acids may be potential tumor markers in IDC. Immunohistochemistry and GC-MS analysis revealed that FASN expression affected the serum fatty acid profiles of patients with IDC. Following FASN knockdown, the migration of SK-Br-3 breast cancer cells was inhibited, and the contents of various fatty acids both inside and outside the cell decreased, while the contents of various fatty acids inside and outside the cell increased following FASN overexpression. The results of the present study revealed that the expression level of FASN affected the content of fatty acids in IDC tissues and breast cancer cell lines, and that FASN-mediated changes in specific fatty acids promoted tumor cell migration.
31
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay, Hai‐Rim Shin, Freddie Bray et al. · International Journal of Cancer · 2010 · 21.4K citations
Christina Fitzmaurice, Christine A. Allen, Ryan M Barber et al. · JAMA Oncology · 2016 · 6.3K citations · Full text
Robert L. Camp, Marisa Dolled‐Filhart, David L. Rimm · Clinical Cancer Research · 2004 · 3.9K citations
Medicine, Biostatistics, Oncology +17
Christina Fitzmaurice · Journal of Clinical Oncology · 2018 · 1.7K citations · Full text
Medicine, Health Policy, Oncology +17